“Efficacy and Safety of Evobrutinib in Relapsing Multiple Sclerosis: A Systematic Review of Randomized Controlled Trials”. Magna Neurologica 3, no. 2 (July 1, 2025): 138–149. Accessed April 2, 2026. https://journal.uns.ac.id/index.php/magna-neurologica/article/view/1929.